Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population  by Selvarajah, Sharmini et al.
International Journal of Cardiology 176 (2014) 211–218
Contents lists available at ScienceDirect
International Journal of Cardiology
j ourna l homepage: www.e lsev ie r .com/ locate / i j ca rdComparison of the Framingham Risk Score, SCORE and WHO/ISH
cardiovascular risk prediction models in an Asian population☆Sharmini Selvarajah a,b,c,⁎, Gurpreet Kaur d, Jamaiyah Haniff a, Kee Chee Cheong e, Tee Guat Hiong d,
Yolanda van der Graaf c, Michiel L. Bots c
a Clinical Research Centre, Kuala Lumpur Hospital, Jalan Pahang, 50586 Kuala Lumpur, Malaysia
b Julius Centre University of Malaya, Department of Social and Preventive Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
c Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
d Institute for Public Health, Ministry of Health Malaysia, Jalan Bangsar, 50590 Kuala Lumpur, Malaysia
e Institute for Medical Research, Ministry of Health Malaysia, Jalan Pahang, 50588 Kuala Lumpur, Malaysia☆ Funding: This work was supported by a grant from t
(NMRR10-731-6916) and is part of theMyCARDIO project
ed by the University of Malaya/Ministry of Higher Educa
Research Grant (Grant number E000010-20001).
⁎ Corresponding author at: Julius Centre University ofM
Preventive Medicine, Faculty of Medicine, University of
Malaysia. Tel.: +60 3 7967 7895; fax: +60 3 7967 4975.
E-mail addresses: s.selvarajah@umcutrecht.nl, s.selvara
http://dx.doi.org/10.1016/j.ijcard.2014.07.066
0167-5273/© 2014 The Authors. Published by Elsevier Irea b s t r a c ta r t i c l e i n f oArticle history:
Received 17 December 2013
Received in revised form 16 May 2014
Accepted 9 July 2014
Available online 15 July 2014
Keywords:
Cardiovascular disease prevention
Mortality
Risk prediction
Risk score
Validation
Background: Cardiovascular risk-prediction models are used in clinical practice to identify and treat high-risk
populations, and to communicate risk effectively. We assessed the validity and utility of four cardiovascular
risk-prediction models in an Asian population of a middle-income country.
Methods:Data from a national population-based survey of 14,863 participants aged 40 to 65 years, with a follow-
up duration of 73,277 person-years was used. The Framingham Risk Score (FRS), SCORE (Systematic COronary
Risk Evaluation)-high and -low cardiovascular-risk regions and the World Health Organization/International
Society of Hypertension (WHO/ISH) models were assessed. The outcome of interest was 5-year cardiovascular
mortality. Discrimination was assessed for all models and calibration for the SCORE models.
Results: Cardiovascular risk factors were highly prevalent; smoking 20%, obesity 32%, hypertension 55%, diabetes
mellitus 18% and hypercholesterolemia 34%. The FRS and SCORE models showed good agreement in risk
stratiﬁcation. The FRS, SCORE-high and -low models showed good discrimination for cardiovascular mortality,
areas under the ROC curve (AUC) were 0.768, 0.774 and 0.775 respectively. The WHO/ISH model showed
poor discrimination, AUC = 0.613. Calibration of the SCORE-high model was graphically and statistically
acceptable for men (χ2 goodness-of-ﬁt, p = 0.097). The SCORE-low model was statistically acceptable for men
(χ2 goodness-of-ﬁt, p = 0.067). Both SCORE-models underestimated risk in women (p b 0.001).
Conclusions: The FRS and SCORE-high models, but not the WHO/ISH model can be used to identify high cardio-
vascular risk in the Malaysian population. The SCORE-high model predicts risk accurately in men but
underestimated it in women.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cardiovascular risk prediction models are important in the preven-
tion and management of cardiovascular diseases. These models are
used in clinical practice to identify and treat high-risk populations as
well as to communicate risk effectively [1]. Currently, there are three
cardiovascular risk prediction models recommended in the Malaysian
clinical practice guidelines for the prevention of cardiovascular diseases;he Ministry of Health, Malaysia
(STeMMProgramme) support-
tion (UM/MOHE) High Impact
alaya, Department of Social and
Malaya, 50603 Kuala Lumpur,
jah@um.edu.my (S. Selvarajah).
land Ltd. This is an open access articlthe Framingham Risk Score (FRS), SCORE (Systematic COronary Risk
Evaluation) and the World Health Organization/International Society
of Hypertension (WHO/ISH) models [2].
There are various concerns when adopting a risk prediction model
for the clinical assessment of a patient to determine treatment options.
First, is the risk score applicable to the local patient setting? It is well
known that the underlying incidence of disease and prevalence of its
risk factors determines the suitability of any risk prediction model.
Secondly, can the risk prediction model be calibrated? In other words,
can it be fully assessed of its clinical utility to predict risk accurately in
the local patient setting? Unfortunately, developing countries often
lack the information on cardiovascular events that are required for a
full calibration of cardiovascular risk prediction models.
InMalaysia, a middle-incomemulti-ethnic developing country, both
factors discussed above are applicable. Thus, these questions remain;
1) Are all the recommended cardiovascular risk-prediction scorese under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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risks? With these concerns in mind, we sought to compare the cardio-
vascular risk prediction models that are recommended in local clinical
practice guidelines; the FRS, high and low risk SCORE and WHO/ISH
risk-prediction models.
2. Methods
The population dataset from the 2006 National Health andMorbidity Survey (NHMS)
was used in this study. The NHMS was a nationwide cross-sectional population-based
survey that assessed cardiovascular risk factors among other health and social indicators.
Details of the study have been published elsewhere and themeasurement of cardiovascu-
lar risk factors has been described in detail [3]. The NHMS had a 91% participation rate for
adults aged 18 and above [3]. For this study, all NHMS participants aged between 40 and
65 years were selected to ensure comparability between the different risk models
assessed. Those with known history of cardiovascular disease were excluded.
Ethics approval was obtained from the Malaysian Medical Research and Ethics
Committee (NMRR ID-10-731-6916). This study complieswith theDeclaration of Helsinki.
2.1. Cardiovascular risk prediction models
Four cardiovascular risk prediction models were assessed; the FRS for global cardio-
vascular risk [4], SCORE-high-cardiovascular risk region (SCORE-high) [5], SCORE-low-
cardiovascular risk region (SCORE-low) [5], and the WHO/ISH — Western Paciﬁc Region
B [6]. A summary of the risk prediction models is given in Appendix A.
The FRS [4], SCORE [5] and WHO/ISH [6] models use information on age, sex, systolic
blood pressure and smoking. The SCORE and WHO/ISH models include information on
total cholesterolwhereas the FRSmodel in thepresent study uses bodymass index instead
of the ratio of total and high-density lipoprotein (HDL) cholesterol. This is because the
NHMS did not collect information on HDL cholesterol. Both the FRS andWHO/ISH include
diabetes in the model.
For both the FRS and SCORE models, the originally developed and validated pre-
dictors and coefﬁcients were used to calculate the predicted cardiovascular risk in the
present study. The cardiovascular risk prediction for the FRS was calculated using the
Framingham equations for general cardiovascular risk provided online (http://www.
framinghamheartstudy.org/risk-functions/cardiovascular-disease/10-year-risk.php). The
FRS equation used a Cox proportional hazards model [4]. Risk estimations for the
SCORE models were calculated using a Weibull proportional hazards regression
equation as provided by Conroy et al. [5]. The original SCORE models do not take
diabetes status into account but it was recommended that risks be multiplied two-
fold for men and four-fold for women with diabetes [5]. This is because cardiovascu-
lar risk in diabetics is higher than non-diabetics; almost in parallel for every conven-
tional cardiovascular risk factor [5]. In our study, the estimated risk in diabetics was
multiplied by three in men, and by ﬁve in women as this is the current estimated
impact of diabetes on cardiovascular risk [7]. Both SCORE models were used, that
for populations at high and low cardiovascular risk populations. This is because it is
unknown which model would perform better in Malaysia. The WHO/ISH risk predic-
tion model does not provide regression equations that can estimate absolute risk for
individuals [6]. The WHO/ISH risk prediction model has risk charts with ﬁve catego-
ries of risk. In this study, each subject's risk category was calculated.
2.2. Cardiovascular risk stratiﬁcation
For eachmodel, cardiovascular risk was stratiﬁed into three categories; low, interme-
diate and high cardiovascular risk. High cardiovascular riskwas deﬁned as ten-year risk of
≥20%, ≥5% and≥30% for the FRS, SCORE andWHO/ISH models, respectively [2,6,7]. Low
risk was deﬁned as b10% for the FRS [2] and WHO/ISH models [6] and b1% for both the
SCOREmodels [7]. All other valueswere in the intermediate risk group. Spearman's corre-
lation coefﬁcient was used to assess the correlation between the rankings of each subject's
absolute cardiovascular risk. Agreement between different models was determined by
lower numbers of population misclassiﬁcation in extremes of risk categories.
2.3. Outcome of interest for model performance
The 5-year risk of cardiovascular mortality was the outcome of interest in this study.
Non-fatal cardiovascular events were not considered, because despite a relatively good
healthcare system, estimates of incidence of coronary heart disease, stroke and other
cardiovascular events assessed by many cardiovascular risk-prediction models cannot be
obtained. Cardiovascular causes of death were fatal events described in the International
Classiﬁcation of Diseases (ICD)-10 codes I10–I15 (hypertensive diseases), I20–25
(ischemic heart diseases), I60–I69 (cerebrovascular diseases), I70 and I71 (other athero-
sclerosis), which were used in the SCORE models [5].
Mortality data from 1st January 2006 till 31st December 2010 for the NHMS popula-
tion were obtained via record linkages with the Malaysian National Registration Depart-
ment. All Malaysians have a unique numerical identiﬁcation number given at birth by
the National Registration Department. This unique identiﬁcation number is used for all
ofﬁcial matters, including death registrations. Death registrations are compulsory in the
country. The IBM® InfoSphere® QualityStage (http://www-01.ibm.com/software/data/
infosphere/qualitystage/) was used for record matching purposes.Kaplan–Meier curves were plotted for 5-year cardiovascular mortality risk, by risk
stratiﬁcation for the four risk prediction models.
2.4. Statistical methods
Missing data was reviewed and determined if it was missing at random. Imputation
was performed since several studies have indicated that complete case analyses leads to
biased results [8,9]. Continuous variables with ≤2% missing were imputed using mean
or median values where applicable. Single imputation using a linear regression with a
random error term was done for total cholesterol (7% missing).
2.5. Model performance
Validity of predictionmodels was assessed based on discrimination and calibration of
the models. Discrimination is the ability to categorize those with and without disease
based on predictive values. Calibration is the measure of how accurately the predicted
risk matched the observed risk. Utility of the models in this study was based on discrimi-
nation and calibration except for two models, the FRS and WHO/ISH. Calibration was not
assessed for the FRS andWHO/ISHmodels because thesemodels estimate the 10-year risk
of fatal and non-fatal cardiovascular events. In our study, only fatal cardiovascular events
were available.
2.5.1. Discrimination
Discriminationwas assessedusing the areaunder the receiver operating characteristic
(ROC) curve. A value of N0.75 was considered good discrimination. Model comparisons
were statistically tested for differences in the area under the ROC (AUC). This method
has been proven acceptable for comparing ordinal tests (WHO/ISH) with continuous
tests (FRS and SCORE) [10].
2.5.2. Calibration
Model calibration was tested for two models; SCORE-high and SCORE-low. As the
cardiovascular mortality events were available for ﬁve years in this study, and not 10 as
in the original SCORE model, calibration was tested for 5-year mortality. Only for model
calibration, all relevant regression equations by Conroy et al. [5]weremodiﬁed to estimate
the 5-year risk of fatal cardiovascular disease. E.g., the underlying survival probabilities
were calculated separately for each person's current age and for their age in 5 years
time [5].
Calibration was assessed statistically using a chi-square goodness-of-ﬁt test to deter-
mine if the observed 5-year cardiovascular mortality rates differed signiﬁcantly from the
expected [11]. Calibration was also determined graphically by plotting the observed and
expected 5-year mortality events, grouped according to deciles of predicted probabilities.
For all analyses, p values less than 0.05 were considered statistically signiﬁcant. Anal-
yses were performed using IBM SPSS Statistics for Windows, Version 20.0 (IBM Corp.,
Armonk, NY, USA) and Stata Statistical Software: Release 11.0 (College Station, TX: Stata
Corporation LP).
3. Results
There were a total of 14,983 participants aged between 40 and
65 years. 120 participants with existing cardiovascular diseasewere ex-
cluded. Of the remaining 14,863 participants, almost 50%were between
the ages 40 and 49 (Table 1). 45.3% were men. Cardiovascular risk fac-
tors were highly prevalent; more in women than in men. There were
a total of 73,277 person-years of follow-up with a mean duration of
4.93 years. The 5-year cardiovascular and all-cause mortality rate was
1% (148 events) and 3.2% (475 events) respectively. There were 98
cardiovascular mortality events in men, with a follow-up duration of
33,088 person-years and 50 events in women, with a follow-up dura-
tion of 40,189 person-years. Among those who died, 82.4% had hyper-
tension, 44.6% had hypercholesterolemia, 39.9% had diabetes mellitus,
4.7% had impaired glucose tolerance and 74.3% were overweight or
obese. Of the 148 cardiovascular mortality events, 65.5% were due to is-
chemic heart disease, 22.3% due to cerebrovascular disease and 12.2%
due to other cardiovascular causes of death. 73% of cardiovascular
causes of death were medically certiﬁed; 78% for men and 64% for
women.
3.1. Cardiovascular risk stratiﬁcation and mortality distribution
Fig. 1 depicts the distribution of the cardiovascular risk categories for
the FRS, SCORE and WHO/ISH risk-prediction models. In men, all score
models except theWHO/ISHmodel showed similar trends in risk strat-
iﬁcation. Despite the high proportions of cardiovascular risk factors
prevalent in this study population, the WHO/ISH model classiﬁed
Table 1
Characteristics of study participants.
Variables Overall Men Women p value
n 14,863 6739 8124
Age (years) 50.4 (7) 50.6 (7.1) 50.1 (7) b0.001
Age groups (years) b0.001
40–49 49.7 48.1 51.1
50–59 37.2 38 36.6
60–65 13 13.9 12.3
Male sex 45.3 100 NA
Race 0.046
Malay 55.1 54.6 55.6
Chinese 23.6 24.2 23.1
Asian Indian 8.4 7.9 8.9
Others 12.8 13.2 12.5
Residence 0.04
Urban 58.5 57.6 59.3
Rural 41.5 42.4 40.7
Education (years of schooling) b0.001
No schooling 12.1 6.4 16.9
Primary (≤6 years) 40.3 39.2 41.1
Secondary (7–12 years) 41.1 45.4 37.5
Tertiary (≥13 years) 6.5 9 4.5
Household income b0.001
bMYR2000 (USD 634) 63.1 61.3 64.6
MYR2000–3999 (USD 635–1267) 24 24.8 23.3
≥MYR4000 (USD 1268) 12.9 13.9 12.2
Smoking 20 42.1 1.7 b0.001
Physical examination & investigations
Systolic blood pressure
(mm Hg)
139 (22.2) 138.6
(20.7)
139.3
(23.4)
0.04
Diastolic blood pressure
(mm Hg)
84.2 (13) 83.7 (12.6) 84.6 (13.4) b0.001
Body mass index (kg/m2) 25.8 (4.8) 25.1 (4.3) 26.4 (5.2) b0.001
Waist circumference (cm) 85.1 (12.4) 86.7 (11.8) 83.8 (12.6) b0.001
Total cholesterol (mmol/l) 4.8 (1.1) 4.7 (0.9) 4.9 (1.1) b0.001
Hypertension 54.9 52.8 56.7 b0.001
Hypercholesterolemia 33.8 30.4 36.6 b0.001
Diabetes 17.1 16.7 17.5 0.03
Overweight (BMI 23.5 b x b 25) 40.4 44.1 37.3 b0.001
Obesity (BMI N =25) 32 25.3 37.5 b0.001
Data are % for categorical variables and mean (sd) for continuous variables.
MYR Malaysian ringgit, USD United States dollar.
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all models showed similar trends. However, as withmen, theWHO/ISH
model had the highest classiﬁcation of low risk populations.
The 5-year cardiovascularmortality rates for all models increased as
cardiovascular risk increased (Fig. 2). All showed similar trends and
were able to distinguish risk categories in men. However, in women,
only the FRS model was able to distinguish differences in mortality
risk for the three cardiovascular risk categories. With the SCORE and
WHO/ISH models, cardiovascular mortality rates among the intermedi-
ate and high risk categories overlapped substantially.
3.2. Comparison of cardiovascular risk-prediction models
The agreement for risk categorization and correlation of scores be-
tween the FRS and SCORE models was good for both men and women.
There was hardly any misclassiﬁcation between the extremes of risk
categories in these models. There was slightly better correlation
between the FRS and the SCORE-high model (Table 2). There was poor
correlation between all models with the WHO/ISH model.
3.2.1. Model performance
The FRS, SCORE-high and SCORE-low models showed good dis-
crimination for cardiovascular mortality (Table 3), with slightly bet-
ter performance in the SCOREmodels. TheWHO/ISHmodel had poor
discrimination for men and women. Model comparisons for area
under the curve showed a p value of b0.0001 for men and women(Fig. 3). The WHO/ISH model was statistically signiﬁcantly different
from the FRS, SCORE-high and SCORE-low models.
Graphically, the SCORE-high model for males showed good agree-
ment between the predicted and observed mortality events, except for
the highest decile of probabilities (Fig. 4). There was poor agreement
for women. Statistically, calibration of the SCORE-high model was
acceptable for men but poor for women, with a χ2 goodness-of-ﬁt =
14.79, p value of 0.097 and χ2 = 38.07, p value b 0.001 respectively.
Graphically, there was less agreement between observed and predicted
risk for men in the SCORE-low model as compared to the SCORE-high
model, but calibration was acceptable with a χ2 goodness-of-ﬁt =
16.03, p value 0.066. For women, there was poor calibration visually
and statistically with a χ2 goodness-of-ﬁt = 43.62, p value b 0.001.
Both SCORE models underestimated the risk in women.
4. Discussion
Our study conﬁrmed that the FRS and both SCORE models, but not
the WHO/ISH model can stratify cardiovascular risk in the Malaysian
population. The SCORE-high model could accurately predict mortality
risk in men, suggesting that Malaysia is a high cardiovascular risk coun-
try. The ﬁndings of this study provide evidence that despite having sim-
ilar variables in themodel, not all cardiovascular risk-predictionmodels
can accurately identify high-risk individuals. This conﬁrms that the
performance of predictionmodels have to be assessed in the population
of interest prior to adoption into clinical practice [1].
Cardiovascular risk-prediction models in limited resource settings
have a very important role. The model cut-off point should sufﬁciently
distinguish between the high and low-cardiovascular risk so as to opti-
mize treatment for those who will beneﬁt the most [11]. TheWHO/ISH
cardiovascular risk prediction model has been recommended for risk
stratiﬁcation in countries with insufﬁcient resources [12]. The main
drive for this recommendation even though there has been no pub-
lished evidence on its performance [13] is that it provides charts with
and without total cholesterol. The WHO/ISH model used in this study
included total cholesterol levels, yet it could not accurately stratify car-
diovascular risk. Our studyunderscored that unless theWHO/ISHmodel
has been validated, it should not be used for cardiovascular risk
stratiﬁcation.
The implications of using the WHO/ISH risk prediction model with-
out prior validation are worrying. In the Malaysian population, the
WHO/ISH model incorrectly categorized most people into the low car-
diovascular risk group. This is detrimental to the prevention and control
of cardiovascular disease since resources would be spent on screening,
yet high-risk individuals would be under-identiﬁed, leading to higher
rates of under-treatment and subsequently more complications. As
the burden of cardiovascular morbidity and mortality is disproportion-
ately higher in developing countries, misclassiﬁcation of high cardiovas-
cular risk at the crucial period for initiating or optimizing treatment
strategies is unacceptable. It may derail any preventive effort.
To our knowledge, this is the ﬁrst study that has evaluated the per-
formance of the WHO/ISH model. However, other studies that have
used the WHO/ISH model for cardiovascular risk stratiﬁcation in the
general population have similarly shown that theWHO/ISH risk predic-
tion model identiﬁes most people as having low cardiovascular risk.
Dugee et al. showed that the proportion of low cardiovascular risk as
categorized by the WHO/ISH model were 97% (95% CI 96.4, 97.7) for
Cambodia, 89.6% (95%CI 86.8, 92.2) for Mongolia and 94.4% (95%CI 91,
97.8) for Malaysia [14]. In Jamaica, the prevalence of low cardiovascular
risk was 89.3% [15] and in Cuba 89.7% [16], as determined by the
WHO/ISH risk-models for their respective regions. All these studies
noted that the prevalence of cardiovascular risk factors was high
but it did not translate into high cardiovascular risk categorization.
The FRS model showed good discrimination for both sexes at the
quantitative level and at the recommended cut-off of 20% for high car-
diovascular risk in our study. The ability of D'Agostino's FRS model to
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Fig. 1. Comparison of cardiovascular risk categories for the Framingham Risk Score (FRS), SCORE andWHO/ISH risk prediction models (y-axis reﬂect percentage of individuals).
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FRS had an AUC of 0.73 (95%CI 0.69, 0.77) for men and 0.76 (95%CI 0.72,
0.80) for women [17], which is similar to that found in our study. In
Spain, the AUC for men was 0.79 (95%CI 0.72, 0.86) and women 0.78
(95%CI 0.71, 0.85) [18]. In Tehran, the AUC for men was 0.77 (95%CI
0.74, 0.81) and women 0.82 (95%CI 0.79, 0.85) [19]. However, our
study used the BMI version of the 2008 FRS equation (instead of
total cholesterol/HDL cholesterol ratio). The only study validating the
discriminatory performance of the BMI model showed a c-statistic of
0.747 in the multi-ethnic Women's Health Initiative Observational
Cohort [20], which was lower than the 0.758 found in our study.
The SCORE models have been extensively assessed and externally
validated.Most studies prove good discrimination, but some require re-
calibration for optimal performance. Our study ﬁndings are similar to
that of Jorstad et al. who found that in the UK–Norfolk population
both SCORE models had good discrimination, AUC of 0.78 (95%CI 0.75,
0.81), but only one of the models was calibrated, the SCORE-low
model χ2 21.60 (p = 0.02) [21]. In Iceland, similar to the UK–Norfolk
study, both SCORE models had good discrimination; AUC 0.80 (95%CI
0.78, 0.82) for SCORE-high and AUC 0.80 (95%CI 0.77, 0.82) for the
SCORE-low model, with the SCORE-low model being calibrated [22].
In Australia, the SCORE-high model had an AUC of 0.75 (95%CI 0.68,
0.82) for men and 0.70 (95%CI 0.62, 0.79) for women, and the SCORE-
low model had an AUC of 0.75 (95%CI 0.68, 0.83) for men and 0.70
(95%CI 0.62, 0.79) for women [23]. Again the SCORE-low model
performed better, χ2 4.4, p = 0.36 for men, χ2 12.92, p = 0.01 forwomen. The SCORE-low models were also calibrated for the Dutch
population [24]. The SCORE-high model performed poorly in Norway
despite it being categorized as a high cardiovascular risk country; AUC
range was 0.65–0.68 for men and 0.68–0.72 for women. Instead the
SCORE-low model performed better, reiterating the need for each
country to validate any recommended risk prediction model [25].
So far, no SCORE model has been validated for an Asian population.
Our study provides the ﬁrst evidence that the currently available
SCORE-high model accurately predicts risk in men. Although both the
SCORE models showed good discrimination for women when absolute
risks were taken into account, the SCOREmodels were unable to distin-
guishmortality risks between the intermediate and high cardiovascular
risk categories forwomen. This suggests that the cut-off values for inter-
mediate and high cardiovascular risk need to be re-adjusted for women,
to enable clear distinctions in mortality risks for the low, intermediate
and high cardiovascular risk categories, like the FRS. The better discrim-
inatory performance of the SCORE models compared to the FRS seen in
this study may be due two reasons; 1) the inclusion of total cholesterol
levels in themodel, or 2) the use of the same end-points for assessment.
In the original SCORE cohort, the authors used the ‘hard’ endpoint of
fatal cardiovascular disease, which was the same outcome of interest
in our study. The poor calibration seen for the SCORE models in
women may be due to the small number of cardiovascular mortality
events. Women in South East Asian countries have shown low cardio-
vascular causes of mortality unlike other countries [26] and this may
be similar forMalaysia. An alternative explanation is that cardiovascular
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Fig. 2. 5-year cardiovascular mortality rate (y-axis, percentage) by the Framingham Risk Score, SCORE and WHO/ISH risk prediction models.
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Table 2
Agreement of cardiovascular risk categorization and correlation of scores for the
Framingham Risk Score, SCORE and WHO/ISH risk prediction models.
Models Both high or
both low (n)
Both
high (n)
First model*
high/comparator
low (n)
First model*
low/comparator
high (n)
ρ
FRS* and SCORE — high
Overall 8516 2685 3 0 0.889
Men 3076 1995 0 0 0.895
Women 5440 690 3 0 0.848
FRS* and SCORE — low
Overall 8474 1646 24 0 0.890
Men 2842 1146 11 0 0.895
Women 5632 500 13 0 0.85
FRS* and WHO/ISH
Overall 7588 425 2023 3 0.474
Men 1998 240 1588 0 0.516
Women 5590 185 435 3 0.462
SCORE — high* and WHO/ISH
Overall 6522 398 1731 9 0.422
Men 1380 231 1345 0 0.520
Women 5142 167 386 9 0.413
SCORE — low* and WHO/ISH
Overall 8463 367 611 16 0.422
Men 2694 222 428 0 0.519
Women 5769 145 183 16 0.410
ρ, Spearman's correlation coefﬁcient.
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Fig. 3. ROC curves for the FRS, SCORE andWHO/ISHmodels for prediction of cardiovascu-
lar mortality.
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other South East Asian countries [27].
The cardiovascular risk scores assessed in this study are contempo-
rary models used in other countries. The FRS was developed from a sin-
gle cohort, all of whom were Caucasians [4]. The SCORE models were
developed from a variety of cohort studies from different European
countries, also in individuals mostly of Caucasian origin [5]. Despite
the mainly Caucasian ethnicity in the development of these models,
they were able to discriminate cardiovascular risk in the multi-ethnic
Malaysian population. This is most likely because the FRS and SCORE
models were developed from real population cohorts. The WHO/ISH
risk prediction model was not based on actual cohorts [6]. The model
was developed based on a hypothetical cohort that was assigned values
of cardiovascular risk factors using estimates of risk-factor prevalence of
the various regions. Calculation of absolute risk of cardiovascular events
was based on incidence rates estimated from other WHO studies.
Despite having charts speciﬁcally developed for various regions, the
WHO/ISH model for the Malaysian region performed poorly. It is
possible that a WHO/ISH model for a different region may work better.
However, in light of different WHO/ISH regions categorizing most of
their population as having low cardiovascular risk [14–16], it wouldTable 3
Sensitivity, speciﬁcity and discriminative ability for the FRS, SCORE andWHO/ISH models
for 5-year cardiovascular mortality.
Models Cut-off Sensitivity Speciﬁcity AUC (95% CI)
FRS
Overall N20% 61.8 76.8 0.768 (0.734, 0.802)
Men N20% 72.6 63.6 0.751 (0.708, 0.795)
Women N20% 42.4 87.7 0.758 (0.702, 0.815)
SCORE-high
Overall N5% 59.4 79.4 0.774 (0.741, 0.807)
Men N5% 74.5 67.4 0.768 (0.726, 0.809)
Women N5% 32.2 89.3 0.763 (0.711, 0.815)
SCORE-low
Overall N5% 38.2 88.5 0.775 (0.742, 0.807)
Men N5% 46.2 82.8 0.768 (0.726, 0.81)
Women N5% 23.7 93.1 0.761 (0.709, 0.813)
WHO/ISH
Overall N30% 13.3 96.9 0.613 (0.564, 0.662)
Men N30% 16.0 96.4 0.617 (0.556, 0.678)
Women N30% 8.5 97.3 0.597 (0.516, 0.678)
AUC, area under the receiver operating characteristic curve.be more prudent to recommend the use of the FRS with a BMI model
or the SCORE models for cardiovascular risk prediction.
Our study used data froma cohort that is representative of thewhole
population. However, some methodological issues remain. Although
death registrations are compulsory and each citizen can be traced
using a unique identiﬁcation number, there is a low percentage of med-
ically certiﬁed deaths in the country, 57% in 2010 [28]. The other 43% are
certiﬁed by the police. In these instances, cause of death is determined
through interviews with family members regarding the individual's
medical history and hospitalizations. However, in this study, 73% of
the cardiovascular causes of death were medically certiﬁed. Thus, it is
likely that the ﬁndings of this study remain unchanged.
In this study, diabetes status was determined by self-report or a sin-
gle hyperglycemic reading by glucometer. There may be misclassiﬁca-
tion of diabetes status based on a single hyperglycemic reading, but it
is likely to be non-differential. Hence a possible overestimation of risk
in newly diagnosed diabetics may be balanced by an underestimation
of risk in undetected diabetics.
The WHO/ISH risk prediction model has ﬁve points that were used
for model discrimination. This is a less than ideal comparison. However,
unlike the FRS and SCOREmodels, theWHO/ISHmodel regression equa-
tions are unpublished [6] and calculation of absolute risk is not available
SCORE-high SCORE-low
Men Men
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Fig. 4. Observed and predicted cardiovascular mortality events for SCORE-high and SCORE-low cardiovascular risk prediction models, by deciles of probabilities.
217S. Selvarajah et al. / International Journal of Cardiology 176 (2014) 211–218for clinical use. Thus, the discriminative ability shown in this study
represents actual clinical practice.
Calibration of the SCOREmodelswas based on 5-year cardiovascular
mortality events. Actual observed numbers of 10-year events will be es-
sential for adequate calibration of the SCORE models. Aside from this,
the FRS model, which includes the total cholesterol/HDL cholesterol
ratio, is more widely used in cardiovascular risk-prediction. It is
unknown how the more commonly used FRS model would have per-
formed in our population but it is likely to be similar. One study
assessing the discriminatory performance of the FRS model using BMI
showed a c-statistic of 0.747, which was approximately the same as
0.750 of the FRS model using the total cholesterol/HDL cholesterol
ratio [20].
5. Conclusions
Our study highlighted that it is crucial to assess cardiovascular risk-
prediction models prior to clinical use, as not all are created equal. OnlyCharacteristics Framingham Risk Score (FRS) SCORE (Syst
Data source Cohort studies: Framingham Heart Study and
Framingham Offspring Study.
Pooled coho
Population General population in Framingham, Massachusetts,
United States of America
12 cohort st
cohorts) fro
Age range 30–75 40–65
Variables Age, gender, body-mass-index OR total cholesterol
& HDL cholesterol, SBP, smoking status, diabetes,
hypertensive treatment.
Age, gender
Endpoints 10-year risk of cardiovascular events (coronary death,
myocardial infarction, coronary insufﬁciency, angina,
ischemic stroke, hemorrhagic stroke, transient ische-
mic attack, peripheral artery disease, heart failure)
10-year risk
codes 401–4
atherosclero
429.0, 430.0
Scoring mechanism Online calculator/risk equations online Online calcu
Risk equatio
Versions: hi
Appendix A. Characteristics of the FRS, SCORE andWHO/ISH risk predictthe FRS and SCORE models are applicable for use in clinical practice for
the identiﬁcation of patients at high cardiovascular risk in Malaysia.
However, their performance differs by gender. For men, the SCORE-
high model should be recommended because of its performance, and
ease of recalibration when required in the future. For women, the FRS
should be recommended until the SCORE models are recalibrated and
new high cardiovascular risk cut-offs can be identiﬁed.
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